Actual Medicinal Product (AMP) Exemestane 25mg tablets (Kent Pharma (UK) Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Aromasin 25mg tablets (Pfizer Ltd).

Generic
Exemestane
Formulation
Exemestane 25mg tablets
  • Exemestane
    • Exemestane 25mg tablets
      • Exemestane 25mg tablets (Kent Pharma (UK) Ltd)

Alternative Suppliers (32)



Related Formulations (1)